European Society of Cardiology
Skip navigation links
Home
About the ESC
Membership
Communities
Congresses
Education
Guidelines & Surveys
Journals
Initiatives
Welcome to the European Society of Cardiology. Our mission: to reduce the burden of cardiovascular disease in Europe
 

Webcasts - Tuesday 31 August 2010

ESC Congress 2010 recorded presentations

Please find here below a list of webcasts from ESC Congress 2010. Thank you to the presenters who have shared their presentations with us!

PresentationSpeakerTopicDate
Atrial fibrillation - new insightsRole of abnormal intracellular calcium release.Xander Wehrens (US)Arrhythmias / Pacing / Resynchronisation31 Aug 2010
Atrial fibrillation - new insightsCytoskeleton reorganisation.Jan Wilko Schrickel (DE)Arrhythmias / Pacing / Resynchronisation31 Aug 2010
Atrial fibrillation - new insightsNew mechanistic insights from inherited mutations.Ramon Brugada Terradellas (ES)Arrhythmias / Pacing / Resynchronisation31 Aug 2010
Atrial fibrillation - new insightsRole of calcineurin/nuclear factor of activated T-cells signalling.Ulrich Schotten (NL)Arrhythmias / Pacing / Resynchronisation31 Aug 2010
Hot Line III - Cardiovascular disease and rhythm disturbancesDANPACE: The Danish multicenter randomised trial on single lead atrial versus dual chamber pacing in sick sinus syndromeJens Cosedis Nielsen (DK)Arrhythmias / Pacing / Resynchronisation31 Aug 2010
Hot Line III - Cardiovascular disease and rhythm disturbancesDiscussant: DANPACE: The Danish multicenter randomised trial on single lead atrial versus dual chamber pacing in sick sinus syndromeCarina Blomstrom-Lundqvist (SE)Arrhythmias / Pacing / Resynchronisation31 Aug 2010
Hot Line III - Cardiovascular disease and rhythm disturbancesANTIPAF: Angiotensin II-antagonist in paroxysmal atrial fibrillation trialAndreas Goette (DE)Arrhythmias / Pacing / Resynchronisation31 Aug 2010
Hot Line III - Cardiovascular disease and rhythm disturbancesDiscussant: ANTIPAF: Angiotensin II-antagonist in paroxysmal atrial fibrillation trialJohn Camm (UK)Arrhythmias / Pacing / Resynchronisation31 Aug 2010
Meet the Trialist V - AVERROESAVERROES: Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent StrokesStuart J Connolly (CA)Peripheral circulation/stroke31 Aug 2010
Take home messages for practitionersArrhythmia and pacing.Panagiotis Vardas (GR)Arrhythmias / Pacing / Resynchronisation31 Aug 2010
Forum for future leaders in cardiologyDiffuse ST segment elevation and ventricular fibrilation without structural heart disease - a new electrocardiographic presentation of a channelopathy?Ana Lebreiro (PT)Arrhythmias / Pacing / Resynchronisation31 Aug 2010
Grown-up congenital heart disease - how to follow the new ESC GuidelinesUnoperate shunt lesions in adults: when is closure indicated?Helmut Baumgartner (DE)Congenital heart disease / Pediatric cardiology31 Aug 2010
Grown-up congenital heart disease - how to follow the new ESC GuidelinesHow to assess and treat obstructive lesions.Erwin Oechslin (CA)Congenital heart disease / Pediatric cardiology31 Aug 2010
Grown-up congenital heart disease - how to follow the new ESC GuidelinesTetralogy of Fallot after repair: how to follow and when to re-intervene?Philipp Bonhoeffer (UK)Congenital heart disease / Pediatric cardiology31 Aug 2010
Grown-up congenital heart disease - how to follow the new ESC GuidelinesTransposition of the great arteries with atrial switch versus arterial switch: what do we need to look for and how do we react?Folkert Meijboom (NL)Congenital heart disease / Pediatric cardiology31 Aug 2010
Take home messages for practitionersCoronary heart disease.Sigmund Silber (DE)Coronary circulation31 Aug 2010
Preventing heart failure by preventing coronary artery disease progressionEpidemiology of risk factors for coronary artery disease and heart failure.Theresa McDonagh (UK)Heart failure / LV dysfunction31 Aug 2010
Preventing heart failure by preventing coronary artery disease progressionHypertension.Faiez Zannad (FR)Heart failure / LV dysfunction31 Aug 2010
Preventing heart failure by preventing coronary artery disease progressionDislipidemia.John Kjekshus (NO)Heart failure / LV dysfunction31 Aug 2010
Preventing heart failure by preventing coronary artery disease progressionDiabetes.John McMurray (UK)Heart failure / LV dysfunction31 Aug 2010
Take home messages for practitionersHeart failure.Guillaume Jondeau (FR)Heart failure / LV dysfunction31 Aug 2010
Take home messages for practitionersHypertension and peripheral disease.Denis Clement (BE)Hypertension31 Aug 2010
Controversies in percutaneous coronary intervention - a young cardiologist's perspectivePro.Thomas Cuisset (FR)Interventional cardiology31 Aug 2010
Controversies in percutaneous coronary intervention - a young cardiologist's perspectiveContra.Marco Valgimigli (IT)Interventional cardiology31 Aug 2010
Controversies in percutaneous coronary intervention - a young cardiologist's perspectivePro.Thomas Cuisset (FR)Interventional cardiology31 Aug 2010
Controversies in percutaneous coronary intervention - a young cardiologist's perspectiveContra.Marco Valgimigli (IT)Interventional cardiology31 Aug 2010
Controversies in percutaneous coronary intervention - a young cardiologist's perspectivePro.Pim Tonino (NL)Interventional cardiology31 Aug 2010
Controversies in percutaneous coronary intervention - a young cardiologist's perspectiveContra.Marco Roffi (CH)Interventional cardiology31 Aug 2010
Controversies in percutaneous coronary intervention - a young cardiologist's perspectivePro.Pim Tonino (NL)Interventional cardiology31 Aug 2010
Controversies in percutaneous coronary intervention - a young cardiologist's perspectiveContra.Marco Roffi (CH)Interventional cardiology31 Aug 2010
State of the Art on Coronary Artery DiseaseGenetic variants related with lipids metabolism genes as a predictor marker of cardiovascular events on stable coronary artery disease.Ricardo Vieira (BR)Ischaemia / ACS / infarction31 Aug 2010
State of the Art on Coronary Artery DiseasePlaque vulnerability is an important feature of chronic stable coronary disease: a comparison of lesions characteristics in stable angina and acute coronary syndromes from the V-HEART study.Nick Palmer (UK)Ischaemia / ACS / infarction31 Aug 2010
State of the Art on Coronary Artery DiseaseDifferences in clinical presentation and 12-month outcome of NSTEMI and STEMI patients without significant lesions in coronary arteries: analysis from PL-ACS registryAnna Maria Frycz-Kurek (PL)Ischaemia / ACS / infarction31 Aug 2010
Cardiogenic shock - an updatePharmacological management.Doron Zahger (IL)Ischaemia / ACS / infarction31 Aug 2010
Cardiogenic shock - an updateThe role of revascularisation.Christian Joseph Marie Vrints (BE)Ischaemia / ACS / infarction31 Aug 2010
Cardiogenic shock - an updateMechanical support.Susanna Price (UK)Ischaemia / ACS / infarction31 Aug 2010
State of the Art on Coronary Artery DiseaseFrom risk factors to acute coronary syndromes: the known and the unknown.Filippo Crea (IT)Ischaemia / ACS / infarction31 Aug 2010
Hot Line III - Cardiovascular disease and rhythm disturbancesDiscussant: EINSTEIN DVT: Oral rivaroxaban versus standard therapy in the initial treatment of symptomatic deep vein thrombosis and long-term prevention of recurrent venous thromboembolismHarald Darius (DE)Ischaemia / ACS / infarction31 Aug 2010
Hot Line III - Cardiovascular disease and rhythm disturbancesFUTURA OASIS 8: A randomised trial comparing two regimens of adjunctive intravenous unfractionated heparin during PCI in high-risk patients with non-STE-ACS treated with fondaparinuxSanjit Jolly (CA)Ischaemia / ACS / infarction31 Aug 2010
Hot Line III - Cardiovascular disease and rhythm disturbancesDiscussant: FUTURA OASIS 8: A randomised trial comparing two regimens of adjunctive intravenous unfractionated heparin during PCI in high-risk patients with non-STE-ACS treated with fondaparinuxDariusz Dudek (PL)Ischaemia / ACS / infarction31 Aug 2010
Forum for future leaders in cardiologyCoronary angiography of pregnancy-associated coronary artery dissection: a high-risk procedure.Raphael Pedro Martins (FR)Ischaemia / ACS / infarction31 Aug 2010
Forum for future leaders in cardiologyIntroduction.Steen Dalby Kristensen (DK)NA31 Aug 2010
Hot Line III - Cardiovascular disease and rhythm disturbancesAVERROES: Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent StrokesStuart J Connolly (CA)Peripheral circulation/stroke31 Aug 2010
Hot Line III - Cardiovascular disease and rhythm disturbancesDiscussant: AVERROES (Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Strokes)Harald Arnesen (NO)Peripheral circulation/stroke31 Aug 2010
Take home messages for practitionersStroke and imaging.Claudio Rapezzi (IT)Peripheral circulation/stroke31 Aug 2010
Hot Line III - Cardiovascular disease and rhythm disturbancesRESPONSE: Effect of a nurse coordinated prevention program on cardiovascular risk after an acute coronary syndrome: Main results of the RESPONSE trialRon J G Peters (NL)Prevention and rehabilitation31 Aug 2010
Hot Line III - Cardiovascular disease and rhythm disturbancesDiscussant: RESPONSE: Effect of a nurse coordinated prevention program on cardiovascular risk after an acute coronary syndrome: Main results of the RESPONSE trialM Christi Deaton (UK)Prevention and rehabilitation31 Aug 2010
Managing difficult pulmonary embolismAcute pulmonary embolism: to thrombolyse or not?Adrian Jb Brady (UK)Pulmonary circulation31 Aug 2010
State of the Art on Coronary Artery DiseaseInflammatory imbalance assessed by Fetuin-A and CRP level is a Ssrong predictor of outcome in acute coronary syndromes- from fast-MI registryPascal Lim (FR)Thrombosis & platelets, microcirculation31 Aug 2010
Forum for future leaders in cardiologyMitral valve aneurysmal rupture associated with bicuspid aortic valve and aortic valve regurgitation.Oya Yuksel (Turkey)Valvular disease31 Aug 2010



 
Highlight On